Rare diseases
Investigational molecules
Locations
Study on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
ItalyStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
ItalyStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
ItalyStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
ItalyStudy of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer
ItalyWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
ItalyDurvalumab versus standard chemotherapy drug combination in elderly patients with advanced non‑small cell lung cancer
ItalyLong‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study
ItalyTulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
ItalyA study to evaluate the efficacy and safety of zenagamtide in people with obesity
ItalyPhase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis
ItalyA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
